Načítá se...
Statins and PCSK9 inhibitors: What is their role in coronavirus disease 2019?
Statins and proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors interfere with several pathophysiological pathways of coronavirus disease 2019 (COVID-19). Statins may have a direct antiviral effect on severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) by inhibiting its main pr...
Uloženo v:
| Vydáno v: | Med Hypotheses |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier Ltd.
2021
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7724447/ https://ncbi.nlm.nih.gov/pubmed/33333472 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.mehy.2020.110452 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|